The Genomic Landscape of Mucinous Breast Cancer

被引:58
|
作者
Pareja, Fresia
Lee, Ju Youn
Brown, David N.
Piscuoglio, Salvatore
Gularte-Merida, Rodrigo
Selenica, Pier
Paula, Arnaud Da Cruz
Arunachalam, Sasi
Kumar, Rahul
Geyer, Felipe C.
Silveira, Catarina
da Silva, Edaise M.
Li, Anqi
Marchio, Caterina
Ng, Charlotte K. Y.
Mariani, Odette
Fuhrmann, Laetitia
Wen, Hannah Y.
Norton, Larry
Vincent-Salomon, Anne
Brogi, Edi
Reis-Filho, Jorge S.
Weigelt, Britta
机构
[1] Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, 10065, NY
[2] Institute of Pathology, University Hospital Basel, Basel
[3] GenoMed SA, Instituto de Medicina Molecular, Universidade de Lisboa, Lisboa
[4] Department of Medical Sciences, FPO-Canndiolo Cancer Institute, University of Turin, Turin
[5] Départment de Médecine Diagnostique et Théranostique, Institute Curie, Paris
[6] Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
来源
关键词
CARCINOMA; DIFFERENTIATION; PROGRESSION; TUMORS; PURE;
D O I
10.1093/jnci/djy216
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Mucinous carcinoma of the breast (MCB) is a rare histologic form of estrogen receptor (ER)-positive/HER2-negative breast cancer (BC) characterized by tumor cells floating in lakes of mucin. We assessed the genomic landscape of 32 MCBs by whole-exome sequencing and/or RNA-sequencing. GATA3 (23.8%), KMT2C (19.0%), and MAP3K1 (14.3%) were the most frequently mutated genes in pure MCBs. In addition, two recurrent but not pathognomonic fusion genes, OAZ1-CSNK1G2 and RFC4-LPP, were detected in 3/31 (9.7%) and 2/31 (6.5%) samples, respectively. Compared with ER-positive/HER2-negative common forms of BC, MCBs displayed lower PIK3CA and TP53 mutation rates and fewer concurrent 1q gains and 16q losses. Clonal decomposition analysis of the mucinous and ductal components independently microdissected from five mixed MCBs revealed that they are clonally related and evolve following clonal selection or parallel evolution. Our findings indicate that MCB represents a genetically distinct ER-positive/HER2-negative form of BC.
引用
收藏
页码:737 / 741
页数:5
相关论文
共 50 条
  • [41] The genomic landscape of metastatic histologic special types of invasive breast cancer
    Fresia Pareja
    Lorenzo Ferrando
    Simon S. K. Lee
    Francisco Beca
    Pier Selenica
    David N. Brown
    Amir Farmanbar
    Arnaud Da Cruz Paula
    Mahsa Vahdatinia
    Hong Zhang
    Gabriele Zoppoli
    Hannah Y. Wen
    Edi Brogi
    Mark E. Robson
    Pedram Razavi
    Sarat Chandarlapaty
    Britta Weigelt
    Jorge S. Reis-Filho
    npj Breast Cancer, 6
  • [42] Functional Genomic Landscape of Human Breast Cancer Drivers, Vulnerabilities, and Resistance
    Marcotte, Richard
    Sayad, Azin
    Brown, Kevin R.
    Sanchez-Garcia, Felix
    Reimand, Jueri
    Haider, Maliha
    Virtanen, Carl
    Bradner, James E.
    Bader, Gary D.
    Mills, Gordon B.
    Pe'er, Dana
    Moffat, Jason
    Neel, Benjamin G.
    CELL, 2016, 164 (1-2) : 293 - 309
  • [43] An update on the genomic landscape of breast cancer: new opportunity for personalized therapy?
    Daemen, Anneleen
    TRANSLATIONAL CANCER RESEARCH, 2012, 1 (04) : 279 - 282
  • [44] Genomic characterization of the GATA3 mutational landscape in breast cancer
    Mouabbi, Jason A.
    Meric-Bernstam, Funda
    Turova, Polina
    Chernyshov, Konstantin
    Kushnarev, Vladimir
    Kotlov, Nikita
    Brown, Jessica H.
    Clayton, Patrick
    Nomie, Krystle
    Fowler, Nathan
    Tripathy, Debu
    Damodaran, Senthil
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [45] Genomic Landscape of Normal and Breast Cancer Tissues in a Hungarian Pilot Cohort
    Pipek, Orsolya
    Alpar, Donat
    Rusz, Orsolya
    Bodor, Csaba
    Udvarnoki, Zoltan
    Medgyes-Horvath, Anna
    Csabai, Istvan
    Szallasi, Zoltan
    Madaras, Lilla
    Kahan, Zsuzsanna
    Cserni, Gabor
    Kovari, Bence
    Kulka, Janina
    Tokes, Anna Maria
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (10)
  • [46] Expanding the landscape of actionable genomic alterations in metastatic breast cancer: comprehensive genomic profiling for all?
    Hilbers, F. S.
    Aftimos, P.
    ANNALS OF ONCOLOGY, 2020, 31 (08) : 967 - 969
  • [47] Mucinous markers in breast cancer
    Seregni, E
    Botti, C
    Massaron, S
    Martinetti, A
    Ferrari, L
    Molteni, SN
    Bombardieri, E
    TUMORI, 1997, 83 (02) : 550 - 551
  • [48] Comparison of Genomic Instability in Mucinous A and B Carcinomas of the Breast
    Sanchez-Salazar, A.
    Gunn, S. R.
    Yeh, I-T
    LABORATORY INVESTIGATION, 2011, 91 : 62A - 62A
  • [49] Comparison of Genomic Instability in Mucinous A and B Carcinomas of the Breast
    Sanchez-Salazar, A.
    Gunn, S. R.
    Yeh, I-T
    MODERN PATHOLOGY, 2011, 24 : 62A - 62A
  • [50] The genomic landscape of male breast cancers
    Piscuoglio, Salvatore
    Murray, Melissa
    Ng, Charlotte K. Y.
    Rocco, Elena Guerini
    Martelotto, Luciano G.
    Bidard, Francois-Clement
    Eberle, Carey A.
    Fusco, Nicola
    Sakr, Rita A.
    De Mattos-Arruda, Leticia
    Lim, Raymond
    Baslan, Timour
    Hicks, James
    King, Tari A.
    Brogi, Edi
    Norton, Larry
    Weigelt, Britta
    Hudis, Clifford A.
    Reis, Jorge S.
    CANCER RESEARCH, 2015, 75